Results
|
51021.
|
|
|
51022.
|
|
|
51023.
|
|
|
51024.
|
|
|
51025.
|
|
|
51026.
|
|
|
51027.
|
|
|
51028.
|
|
|
51029.
|
|
|
51030.
|
Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. [electronic resource] by
- Ouederni, Monia
- Vincent, Quentin B
- Frange, Pierre
- Touzot, Fabien
- Scerra, Sami
- Bejaoui, Mohamed
- Bousfiha, Aziz
- Levy, Yves
- Lisowska-Grospierre, Barbara
- Canioni, Danielle
- Bruneau, Julie
- Debré, Marianne
- Blanche, Stéphane
- Abel, Laurent
- Casanova, Jean-Laurent
- Fischer, Alain
- Picard, Capucine
Producer: 20120103
In:
Blood vol. 118
Availability: No items available.
|
|
51031.
|
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells. [electronic resource] by
- Candelaria, Myrna
- de la Cruz-Hernandez, Erick
- Taja-Chayeb, Lucia
- Perez-Cardenas, Enrique
- Trejo-Becerril, Catalina
- Gonzalez-Fierro, Aurora
- Chavez-Blanco, Alma
- Soto-Reyes, Ernesto
- Dominguez, Guadalupe
- Trujillo, Jaenai E
- Diaz-Chavez, Jose
- Duenas-Gonzalez, Alfonso
Producer: 20120820
In:
PloS one vol. 7
Availability: No items available.
|
|
51032.
|
|
|
51033.
|
Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502. [electronic resource] by
- Attar, Eyal C
- Johnson, Jeffrey L
- Amrein, Philip C
- Lozanski, Gerard
- Wadleigh, Martha
- DeAngelo, Daniel J
- Kolitz, Jonathan E
- Powell, Bayard L
- Voorhees, Peter
- Wang, Eunice S
- Blum, William
- Stone, Richard M
- Marcucci, Guido
- Bloomfield, Clara D
- Moser, Barry
- Larson, Richard A
Producer: 20130412
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
51034.
|
|
|
51035.
|
|
|
51036.
|
|
|
51037.
|
|
|
51038.
|
|
|
51039.
|
|
|
51040.
|
|